EP3870119A1 - Dispositif et procédé d'extraction et d'injection ophtalmiques - Google Patents

Dispositif et procédé d'extraction et d'injection ophtalmiques

Info

Publication number
EP3870119A1
EP3870119A1 EP19874908.7A EP19874908A EP3870119A1 EP 3870119 A1 EP3870119 A1 EP 3870119A1 EP 19874908 A EP19874908 A EP 19874908A EP 3870119 A1 EP3870119 A1 EP 3870119A1
Authority
EP
European Patent Office
Prior art keywords
source
extraction
injection
needle
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19874908.7A
Other languages
German (de)
English (en)
Other versions
EP3870119A4 (fr
Inventor
Han Nian Marcus ANG
Yi Chong Kelvin TEO
Cheng Sim Anna TAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Singapore Health Services Pte Ltd
Original Assignee
Singapore Health Services Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Health Services Pte Ltd filed Critical Singapore Health Services Pte Ltd
Publication of EP3870119A1 publication Critical patent/EP3870119A1/fr
Publication of EP3870119A4 publication Critical patent/EP3870119A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A61B10/0283—Pointed or sharp biopsy instruments with vacuum aspiration, e.g. caused by retractable plunger or by connected syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00736—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments

Definitions

  • the present invention relates broadly, but not exclusively, to devices and methods for ophthalmic extraction and injection.
  • Age-Related Macular Degeneration (AMD) and diabetic retinopathy (DR) are the leading causes of blindness in the world, with an estimated projection of more than 66 million people affected by the year 2023.
  • AMD Age-Related Macular Degeneration
  • DR diabetic retinopathy
  • VEGF Vascular Endothelial Growth Factor
  • an extraction and injection ophthalmic device comprising: a housing comprising: an injection portion configured to receive an injection source; an extraction portion configured to receive an extraction source; a priming mechanism configured to simultaneously prime both the injection source and the extraction source; a needle selectively in fluid communication with the injection source or the extraction source; wherein on activation of the extraction source, the device is configured to extract a sample through the needle, and on activation of the injection source the device is configured to inject an agent through the needle.
  • the priming mechanism may further comprise a lever communicatively coupled to a spring, such that a translation movement of the lever is configured to compress the spring to simultaneously prime both the injection source and the extraction source.
  • the device may further comprise a manifold configured to selectively connect the needle with the injection source or the extraction source, wherein the manifold comprises a double spool manifold.
  • the device may further comprise shearing means configured to shear excess vitreous humor from the sample to be extracted.
  • the injection source and the extraction source may be removably attached to the housing.
  • the injection source may include a syringe.
  • the extraction source may include any one of: a syringe, a vacutainer or a pump.
  • the device may further comprise an injection button configured to activate the injection source such that the injection portion is in fluid communication with the needle to inject the agent from the injection source to the needle.
  • the device may further comprise an extraction button configured to activate the extraction source such that the extraction portion is in fluid communication with the needle to extract the sample from the needle to the extraction source.
  • the extraction source may be fluidically separated from the injection source such that, in use, the agent does not contact the sample.
  • a method for ophthalmic extraction and injection comprising the steps of: attaching an injection source to an injection portion of an extraction and injection ophthalmic device; attaching an extraction source to an extraction portion of the extraction and injection ophthalmic device; priming, by a priming mechanism of the device, the injection source and the extraction source simultaneously; activating the extraction source to extract a sample through a needle, the needle being in fluid communication with the extraction source of the device, and activating the injection source to inject an agent through the needle, the needle being in fluid communication with the injection source of the device.
  • priming the injection source and the extraction source simultaneously may comprise translating a lever communicatively coupled to a spring, such that the spring is compressed to simultaneously prime both the injection source and the extraction.
  • the method may further comprise shearing, by shearing means, excess vitreous humor from the sample to be extracted.
  • activating the extraction source may comprise depressing an extraction button of the device to extract the sample.
  • activating the injection source may comprise depressing an injection button of the device to inject the agent.
  • the method may further comprise fluidically separating the extracted sample from the injection source.
  • FIGs. 1 A and 1 B show perspective views of a device for ophthalmic extraction and injection, according to an example embodiment.
  • Fig. 1 C shows a perspective view of the device of Fig. 1 A with the cover opened, according to an example embodiment.
  • Fig. 1 D shows a cross-sectional side view of the device of Fig. 1 A, according to an example embodiment.
  • Fig. 2A shows a perspective view of the priming mechanism of the device of Fig. 1 A, according to an example embodiment.
  • Fig. 2B shows a close up plan view of the priming mechanism of Fig. 2A.
  • Fig. 2C shows a plan view of the priming mechanism of Fig 2A.
  • Fig. 2D shows a perspective view of the priming mechanism of the device of Fig. 1 A, according to an alternative embodiment.
  • Fig. 2E shows a close up plan view of the priming mechanism of Fig 2D.
  • Fig. 2F shows a plan view of the priming mechanism of Fig 2D.
  • Fig. 3 shows a cross-sectional functional view of the priming mechanism of the device of Fig. 1A, according to an example embodiment.
  • Figs. 4A-4B show perspective views of a button cover for the injection and extraction button of the device of Fig. 1 A, according to an alternative embodiment.
  • Fig. 5 shows a flow chart illustrating a method for ophthalmic extraction and injection, according to the example embodiments.
  • Figs. 1 A and 1 B show perspective views of a device 100 for ophthalmic extraction and injection, according to an example embodiment.
  • the device 100 includes a housing 102, a needle 104, a nozzle 106, an injection button 108, an extraction button 1 10 and a cover 1 12.
  • the housing 102 may include an injection portion, an extraction portion and a priming mechanism. A detailed view of the priming mechanism, the injection portion and the extraction portion are shown in Figs. 2A-2D and will be explained in more detail below.
  • the injection portion may be configured to receive an injection source 1 14 while the extraction portion may be configured to receive an extraction source 1 16.
  • the injection portion may be adjacent to the extraction portion such that the injection source 1 14 and the extraction source 1 16 are positioned side-by-side. In an alternative embodiment, the injection portion may be above or below the extraction portion such that the injection source 1 14 and the extraction source 1 16 are positioned on top or below one another.
  • the needle 104 is selectively in fluid communication with the injection source 1 14 or the extraction source 1 16 when either the injection button 108 or the extraction button 1 10 is depressed.
  • the injection source 1 14 may be a syringe which can contain an agent that is used to treat retinal disease.
  • the injection portion, together with the injection source 1 14, is in fluid communication with the needle 104 such that on activation of the injection source 1 14 when the injection button 108 is depressed, the device 100 is configured to inject the agent from the injection source 1 14 through the needle 104.
  • the extraction source 1 16 may include any one of: a syringe, a vacutainer or a pump.
  • the extraction portion together with the extraction source 1 16, is in fluid communication with the needle 104 such that on activation of the extraction source 1 16 when the extraction button 1 10 is depressed, the device 100 is configured to extract a sample through the needle 104 to the extraction source 1 16.
  • the extraction source 1 16 is also fluidically separated from the injection source 1 14 such that, in use, the agent in the injection source 1 14 does not contact the sample to be extracted. In this way, contamination of the extracted sample and the agent may be prevented which can advantageously result in providing a safe and reliable way to extract vitreous sample and inject anti-VEGF agents.
  • the priming mechanism includes a lever 1 18 and a spring 120 (as shown in Fig. 1 D) such that the lever 1 18 is communicatively coupled to the spring and a translation movement of the lever 1 18 is configured to compress the spring to simultaneously prime both the injection source 1 14 and the extraction source 1 16.
  • the priming mechanism may also include a plurality of valves which are in communication with the injection source 1 14 and the extraction source 1 16 whereby the plurality of valves are closed to prevent contamination of the agent when the injection source 1 14 and the extraction source 1 16 are primed.
  • the plurality of valves may include at least one duckbill valve.
  • the cover 1 12 may be pivotably mounted to the housing 102 such that the injection source 1 14 and the extraction source 1 16 can be attached or removed from the housing 102 when the cover 1 12 is in an open position. As shown in the Figures, the cover 1 12 is at a closed position after the injection source 1 14 and the extraction source 1 16 are attached to the housing 102.
  • the cover 1 12 may also include a tab which interacts with the injection button 108 and the extraction button 1 10 such that the plurality of valves in the priming mechanism are open when the cover 1 12 is at the open position.
  • Fig. 1 C shows a perspective view of the device of Fig. 1A with the cover 1 12 opened, according to an example embodiment.
  • the cover 1 12 is in the open position with the injection source 1 14 and the extraction source 1 16 attached to the housing 102.
  • the injection source 1 14 and the extraction source 1 16 may also be removed from the housing 102.
  • Fig. 1 D shows a cross- sectional side view of the device of Fig. 1 A, according to an example embodiment.
  • the device 100 as shown in the Figure has the cover 1 12 in a closed position and the needle 104 retracted into the housing 102.
  • the spring 120 of the priming mechanism is at an uncompressed position in the Figure as the injection source and the extraction source have yet to be attached to the housing 102.
  • the nozzle 106 is arranged to receive the needle 104 so that the needle 104 can selectively protrude from the housing 102 when the priming mechanism is ready for priming. It can be appreciated that the needle 104 may retract into the housing 102 via the nozzle 106 when the agent from the injection source 1 14 has been delivered and the sample has been extracted into the extraction source 1 16.
  • the housing 102 may also include a cap (not shown) that is configured to cover the nozzle 106 and the needle 104 for safety reasons when the needle 104 is protruding from the housing 102 even though the device 100 is not in use.
  • the device 100 may include shearing means configured to shear excess vitreous humor from the sample to be extracted by the extraction source 1 16.
  • the shearing means may be part of the needle 104 or may be positioned aft of the needle 104 to shear the excess vitreous humor after the sample is extracted from the needle 104.
  • Fig. 2A shows a perspective view of the priming mechanism 200 of the device of Fig. 1A, according to an example embodiment.
  • the priming mechanism 200 has a fitting 202a configured to receive the needle 104 and a collar 204a arranged to receive the fitting 202a.
  • the priming mechanism 200 may also include a case 208a configured to receive the collar 204a, the injection button 108, the extraction button 1 10, the injection portion and the extraction portion.
  • the priming mechanism 200 may include a first metal collar 206a that is configured to receive the injection portion and a second metal collar 206b configured to receive the extraction portion.
  • the case 208a of the priming mechanism 200 is configured to receive the first and second metal collar 206a 206b.
  • the fitting 202a of the priming mechanism 200 may be a metal luer fitting and the collar 204a may be a metal collar.
  • Fig. 2B shows a close up plan view of the priming mechanism of Fig. 2A
  • Fig. 2C shows a plan view of the priming mechanism of Fig 2A
  • the case 208a of the priming mechanism 200 is arranged to receive the collar 204a, the first metal collar 206a, the second metal collar 206b, the injection button 108 and the extraction button 1 10.
  • Fig. 2D shows a perspective view of the priming mechanism of the device of Fig. 1A, according to an alternative embodiment.
  • the priming mechanism 250 has a fitting 202b configured to receive the needle 104 and a collar 204b arranged to receive the fitting 202b.
  • the priming mechanism 250 may also include a case 208b configured to receive the collar 204b, the injection button 108, the extraction button 1 10, the injection portion and the extraction portion.
  • the fitting 202b of the priming mechanism 250 may be a plastic luer fitting while collar 204b may be a plastic collar.
  • the priming mechanism 250 may also include slip fit liv built into the injection portion and the extraction portion which can eliminate the need for the first and second metal collars 206a, 206b of the priming mechanism 200.
  • Fig. 2E shows a close up plan view of the priming mechanism of Fig 2D
  • Fig. 2F shows a plan view of the priming mechanism of Fig 2D.
  • the case 208b of the priming mechanism 250 is arranged to receive the collar 204b, the injection portion 210, the extraction portion 212, the injection button 108 and the extraction button 1 10.
  • the case 208a of the priming mechanism 200 ( Figure 2A) is larger than the case 208b of the priming mechanism 250.
  • the case 208b directly receives the injection portion 210 and the extraction portion 212 while the case 208a receives the injection portion and the extraction portions 210, 212 via the first metal collar 206a and the second metal collar 206b.
  • the distance between the injection button 108 and the extraction button 1 10 in priming mechanism 250 is more than the distance between the injection button 108 and the extraction button 1 10 in priming mechanism 200 ( Figure 2A).
  • the positioning of the plurality of valves (not shown) in priming mechanism 250 may also be different from those of priming mechanism 200.
  • Each of the priming mechanisms 200, 250 may also include a plurality of internal ports configured to allow fluid communication between the needle 104 and the injection portion 210 or the extraction portion 212.
  • Figs. 3A-3D show cross-sectional functional views 300 of the priming mechanism of the device of Fig. 1A, according to an example embodiment.
  • the priming mechanism may comprise a manifold of a double spool design having a low profile which may lead to a pen-styled grip design of the device 100. Flaving a pen- styled grip design may be advantageous in providing a better hold or grip of the device 100 in order to achieve a better control while operating the device 100 close to the patient.
  • Fig. 3A-3D show cross-sectional functional views 300 of the priming mechanism of the device of Fig. 1A, according to an example embodiment.
  • the priming mechanism may comprise a manifold of a double spool design having a low profile which may lead to a pen-styled grip design of the device 100. Flaving a pen- styled grip design may be advantageous in providing a better hold or grip of the device 100 in order to achieve a better control while operating the device 100 close to the patient.
  • the priming mechanism is at a state when the injection source 1 14 and the extraction source 1 16 are yet to be attached to the housing 102.
  • the cover 1 12 of the housing 102 is at the open position and both the injection button 108 and the extraction button 1 10 are depressed.
  • the plurality of valves (not shown) of the priming mechanism are open which may allow the needle 104 to be in communication with both the injection portion 210 and the extraction portion 212.
  • the lever 1 18 is pulled away from the needle which compresses the spring 120 and simultaneously primes the injection source 1 14 and the extraction source 1 16.
  • the injection button 108 and the extraction button 1 10 are at an elevated position so that the needle 104 is not in communication with both the injection portion 210 and the extraction portion 212.
  • a vacuum is also created at the extraction portion 212.
  • the extraction button 1 10 is depressed to activate the extraction source 1 16, thereby only allowing communication between the needle 104 and the extraction portion 212.
  • the vacuum previously created at the extraction portion 212 allows the extraction source 1 16 to extract the sample via the needle 104.
  • the injection button 108 is depressed to activate the injection source 1 14.
  • the extraction button 1 10 returns to the elevated position as shown in Fig. 3D. This allows communication only between the needle 104 and the injection portion 210.
  • the agent contained in the injection source 1 14 is thus delivered to the patient via the needle 104.
  • Figs. 4A-4B show perspective views of a button cover 400 for the injection and extraction button of the device of Fig. 1A, according to an alternative embodiment.
  • the button cover 400 may include a spring well 402 configured to house the spring 120 of the priming mechanism and a spool slot 404.
  • the button cover 400 in this embodiment may allow the injection button 406 and the extraction button 408 to adopt a front and back configuration, which can prevent the accidental depression of the injection button 406 or the extraction button 408. It can also prevent arching of a user’s fingers over the injection and extraction buttons 406, 408 which may improve usability and ergonomics.
  • Fig. 5 shows a flow chart illustrating a method 500 for ophthalmic extraction and injection, according to the example embodiments.
  • the method comprises at step 502 attaching an injection source to an injection portion of an extraction and injection ophthalmic device.
  • the method includes attaching an extraction source to an extraction portion of the extraction and injection ophthalmic device.
  • the method includes priming, by a priming mechanism of the device, the injection source and the extraction source simultaneously. Priming the injection source and the extraction source simultaneously may include translating a lever communicatively coupled to a spring, such that the spring is compressed to simultaneously prime both the injection source and the extraction.
  • the method includes activating the extraction source to extract a sample through a needle, the needle being in fluid communication with the extraction source of the device.
  • the method includes activating the injection source to inject an agent through the needle, the needle being in fluid communication with the injection source of the device.
  • the method may further include shearing, by shearing means, excess vitreous humor from the sample to be extracted; activating the extraction source comprises depressing an extraction button of the device to extract the sample; and activating the injection source comprises depressing an injection button of the device to inject the agent.
  • the device and method for ophthalmic extraction and injection as described herein may be used to perform biopsy and injection simultaneously with only a single device.
  • the injection and extraction sources may be disposable and compatible with standard therapeutics and syringe fittings.
  • the device and method as disclosed may maintain intraocular pressure during injection of the agent and may have a low risk of retinal detachment during vitrectomy, i.e. extraction of the vitreous humor gel of a patient.
  • the device and method may also result in little or no damage to the lens or retinal structures while having a clean extraction of vitreous humor.
  • the device and method may also be used to monitor Vascular Endothelial Growth Factor levels from biopsy for patient-tailored therapy.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L'invention concerne un dispositif et un procédé d'extraction et d'injection ophtalmiques. Le dispositif comprend un boîtier comprenant : une partie d'injection configurée pour recevoir une source d'injection ; une partie d'extraction configurée pour recevoir une source d'extraction ; un mécanisme d'amorçage configuré pour amorcer simultanément à la fois la source d'injection et la source d'extraction ; une aiguille sélectivement en communication fluidique avec la source d'injection ou la source d'extraction ; l'activation de la source d'extraction, le dispositif étant configuré pour extraire un échantillon à travers l'aiguille, et lors de l'activation de la source d'injection, le dispositif étant configuré pour injecter un agent à travers l'aiguille.
EP19874908.7A 2018-10-26 2019-10-24 Dispositif et procédé d'extraction et d'injection ophtalmiques Pending EP3870119A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201809514S 2018-10-26
PCT/SG2019/050525 WO2020086002A1 (fr) 2018-10-26 2019-10-24 Dispositif et procédé d'extraction et d'injection ophtalmiques

Publications (2)

Publication Number Publication Date
EP3870119A1 true EP3870119A1 (fr) 2021-09-01
EP3870119A4 EP3870119A4 (fr) 2022-07-20

Family

ID=70332737

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19874908.7A Pending EP3870119A4 (fr) 2018-10-26 2019-10-24 Dispositif et procédé d'extraction et d'injection ophtalmiques

Country Status (5)

Country Link
US (1) US20220000661A1 (fr)
EP (1) EP3870119A4 (fr)
CN (1) CN113226228A (fr)
SG (1) SG11202104174UA (fr)
WO (1) WO2020086002A1 (fr)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716363A (en) * 1996-04-15 1998-02-10 Josephberg; Robert Gary Pars plana vitrectomy tool
US6309374B1 (en) * 1998-08-03 2001-10-30 Insite Vision Incorporated Injection apparatus and method of using same
US6428528B2 (en) * 1998-08-11 2002-08-06 Antares Pharma, Inc. Needle assisted jet injector
NZ514684A (en) * 1999-04-16 2003-04-29 Powderject Res Ltd Needleless syringe
CN1874729A (zh) * 2003-11-06 2006-12-06 维诺德·B.·希德哈姆 针抽吸活组织检查设备和方法
DE102005022532A1 (de) * 2005-05-17 2006-11-23 Tecpharma Licensing Ag Verabreichungsvorrichtung mit Zwangs-Priming
EP1912574A4 (fr) * 2005-08-10 2010-08-04 Insight Instr Inc Outils permettant d'extraire des echantillons du corps vitre d'un oeil
GB2461089B (en) * 2008-06-19 2012-09-19 Cilag Gmbh Int Injection device
DE202009003009U1 (de) * 2009-03-03 2009-06-25 Dieter Hölzle Technik-Projekte GmbH Injektionsvorrichtung mit Injektionsvolumeneinstellung
US8287494B2 (en) * 2009-03-23 2012-10-16 Colin Ma Intravitreal injection devices and methods of injecting a substance into the vitreous chamber of the eye
CN101732792A (zh) * 2009-11-26 2010-06-16 耿燕 医用玻璃体腔注射器
WO2011141907A1 (fr) * 2010-05-10 2011-11-17 Medimop Medical Projects Ltd. Injecteur précis de faible volume
US8475403B2 (en) * 2010-08-03 2013-07-02 Cook Medical Technologies Llc Aspirating and injecting device with biased closed distal opening
WO2013003620A2 (fr) * 2011-06-28 2013-01-03 Forsight Vision4, Inc. Procédés et appareil de diagnostic
US10300201B2 (en) * 2012-02-06 2019-05-28 Unl Holdings Llc Plunger sub-assemblies and auto-injectors having low retraction activation force
JOP20200175A1 (ar) * 2012-07-03 2017-06-16 Novartis Ag حقنة
US9549849B2 (en) * 2012-09-13 2017-01-24 Alcon Research, Ltd. Systems and methods for reinjection of processed vitreous humor
KR20140070333A (ko) * 2012-11-30 2014-06-10 국립암센터 생체 조직 채취 장치
PL3054856T3 (pl) * 2013-10-13 2021-06-14 V.V.T. Med Ltd. Urządzenie do zsynchronizowanego wstrzykiwania i zasysania
CA2960278A1 (fr) * 2014-09-11 2016-03-17 Psivida Us, Inc. Appareil d'injecteur
SG11201808269YA (en) * 2016-04-21 2018-11-29 Singapore Health Serv Pte Ltd An injection and extraction ophthalmic device
CN106730169B (zh) * 2016-12-16 2018-03-09 中南大学湘雅二医院 用于眼部注射的注射装置

Also Published As

Publication number Publication date
SG11202104174UA (en) 2021-05-28
WO2020086002A1 (fr) 2020-04-30
EP3870119A4 (fr) 2022-07-20
US20220000661A1 (en) 2022-01-06
CN113226228A (zh) 2021-08-06

Similar Documents

Publication Publication Date Title
US20070038174A1 (en) Ophthalmic injector system
US20190175825A1 (en) Gas-powered fluid injection system
EP3349826B1 (fr) Dispositif d'injection ophtalmique
US20090318856A1 (en) Sampling Ocular Fluid
US20240082500A1 (en) Device and method for intraocular fluid injection
JP2008525109A (ja) 点眼剤投与装置
JP6694882B2 (ja) デュアルモード硝子体切除手術システム
CN107920892B (zh) 用于插入人工晶状体的液压注入器以及方法
CN109069290A (zh) 注射和提取眼科装置
US20220000661A1 (en) Device and method for opthalmic extraction and injection
US7879006B2 (en) Injection aid for anterior juxtascleral depot
Bhatia et al. New Ahmed valve designs
Pan et al. Surgical removal of subfoveal perfluorocarbon liquid using combined flute needle and vacuum aspiration in silicone oil-filled eyes: A novel technique to remove subfoveal PFCL
CN108339176A (zh) 一种安全型静脉输液针
CN209529821U (zh) 一种安全型静脉输液针及一种输液器
JP2023528219A (ja) 硝子体複合サンプリング用硝子体内注射装置
US20150223978A1 (en) Intraocular Injection Device
CN109431678A (zh) 经巩膜角膜药物传输系统
JP2019518567A (ja) ボーラス再充填インジケータ
EP4374834A1 (fr) Ensemble d'injection ophtalmique, dispositif d'injection, et procédé d'utilisation
US20160121051A1 (en) Injector for intraocular injection
Ernst et al. Surgical drainage of a pigment epithelial detachment in neovascular age-related macular degeneration
EP3003436A1 (fr) Injecteur pour injection intraoculaire

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210518

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220621

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 10/02 20060101ALI20220614BHEP

Ipc: A61F 9/00 20060101AFI20220614BHEP